Lorelei Mucci presents at the 2017 Advanced Prostate Cancer Consensus Conference in St. Gallen, Switzerland, "International Registry To Improve Outcomes in Men With Advanced Prostate Cancer-IRONMAN".  This exclusvie video lecture includes: background, study objectives, overview of design, and what make the IRONMAN registry so unique.

Related Content:

Watch: IRONMAN - A Better Understanding of the Variation in Care and Treatment - Daniel George

Watch: Lorelei Mucci and Philip Kantoff on Outcomes Research and the IRONMAN Project

View the slides

View Interview from the APCCC with Lorelei Mucci and Philip Kantoff on Outcomes Research and the IRONMAN Project

Access to all Advanced Prostate Cancer Consensus Conference Video Coverage

Read the 2017 APCCC Report on Management of Patients with Advanced Prostate Cancer

Biography:
Lorelei Mucci ScD, MPH is an associate professor of epidemiology at the Harvard School of Public Health, and she co-leads the Cancer Epidemiology program at the Dana Farber/Harvard Cancer Center. She has more than 10 years of research and teaching experience in cancer epidemiology, with a focus on prostate cancer. As a primary or co-investigator on several funded studies, she bridges population science and molecular biology to look across the spectrum of prostate cancer incidence, cancer mortality and somatic alterations. The overarching goals of this multidisciplinary research are to reduce mortality and suffering associated with prostate cancer and to improve overall health among men. Her work puts her in collaboration with a renowned group of prostate cancer investigators and clinicians from around the world on a number of groundbreaking studies including the Nordic Twin Study of Cancer (NorTwinCan), the Prostate Cancer Patho-epidemiology Collaboration (PC)2, and Steps for Prostate Cancer Health and Survival (SPaRTACuS), a walking intervention study among men with prostate cancer